The myelodysplastic/myeloproliferative disorders: the interface

被引：12

作者：

Bennett, JM ^{[1
]}

机构：

[1] Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Dept Med Pathol & Lab Med, Rochester, NY 14642 USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2003年 / 17卷 / 05期

关键词：

CHRONIC MYELOMONOCYTIC LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; MYELODYSPLASTIC SYNDROMES; MARROW TRANSPLANTATION; TOPOTECAN;

D O I：

10.1016/S0889-8588(03)00086-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Most patients with myelodysplastic syndromes can be identified easily and separated from patients who have myeloproliferative disorders. A few have overlapping features, however, with evidence of morphologic dysplasia and a proliferative advantage of one or more of the myeloid differentiating cell lines. For practical purposes and therapeutic considerations, chronic myelomonocytic leukemia is viewed now as a composite disorder along with atypical chronic myeloid leukemia and juvenile myelomonocytic leukemia.

引用

页码：1095 / +

页数：7

共 20 条

[1]

Anderson JE, 1996, BLOOD, V87, P51

[2] THE CHRONIC MYELOID LEUKEMIAS - GUIDELINES FOR DISTINGUISHING CHRONIC GRANULOCYTIC, ATYPICAL CHRONIC MYELOID, AND CHRONIC MYELOMONOCYTIC LEUKEMIA - PROPOSALS BY THE FRENCH-AMERICAN-BRITISH-COOPERATIVE-LEUKEMIA-GROUP [J].